NCT04071782View on ClinicalTrials.gov

Investigating the Safety and Efficacy of the Treatment With the Selution Sirolimus Coated Balloon in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia From Singapore

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

July 30, 2020

Study Completion Date

January 30, 2021

Conditions
Critical Limb Ischemia
Interventions
DEVICE

Drug Coated Balloon

SELUTION DCB will be used during lower limb angioplasty for treatment of lesions that are TASC C and D, in patients with Critical Limb Ischemia

Trial Locations (1)

169608

Singapore General Hospital, Singapore

All Listed Sponsors
lead

Singapore General Hospital

OTHER

NCT04071782 - Investigating the Safety and Efficacy of the Treatment With the Selution Sirolimus Coated Balloon in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia From Singapore | Biotech Hunter | Biotech Hunter